In France
NeurOptimal® Neurofeedback was the subject of a study for the treatment of Attention Deficit and Hyperactivity Disorder (ADHD) at the Laboratory of Functional Neurosciences and Pathologies of the University Hospital of Amiens (UMR 8160, CNRS unit) and has been the subject of a scientific publication.
A study of the Pitié Salpêtrière was conducted in 2013 by Nathalie Gunther & Noëlle Duforest clinical psychologists, on the impact of NeurOptimal® Neurofeedback on patients with temporal frontal pathologies, on stress, caregiver anxiety and the couple relationship.
In Italy
A preliminary study on patients suffering from tinnitus was undertaken in Italy with the non-linear NeurOptimal® neurofeedback.
These volunteers were subjected to a series of sessions, following which data from audiometric measurements and self-assessment questionnaires were collected regarding discomfort caused by tinnitus, level of pathological concern, depression, anxiety, stress and sleep quality.
The results obtained in this study are promising and seem to confirm the particularity of this technique, which is based on the fundamental principles of brain activity, self-regulation, neuroplasticity and learning.
In the United States
A PUBMED (Foundation for Applied Brain Research in Ohio Cleveland USA) study, conducted in 2013 by J. Alvarez, Fl. Meyer, Dl Granoff, A. Lundy, showed the impact of Dynamical Neurofeedback™ on Post Cancer Cognitive Impairment.
In Canada
An independent study was conducted in 2014 by Shane Parkhill, Bsc. Eng. under the supervision of Charlène Zietsma, Ph. D (Next Delta Consulting). This study was conducted with several hundred practitioners using the NeurOptimal software, totalling nearly 3 million hours of neurofeedback sessions.
>link to the study
here
(English).